ArticleJAMA2022
Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply.
Silje Watterdal Syversen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it